Home › Blog › Weight Loss › Mounjaro London

Mounjaro London 2026: NHS vs Private, Prices From £139, Waiting Times and How to Get Started Today

Mounjaro in London: The Essential Guide

Mounjaro (tirzepatide) is the UK’s most prescribed weight loss injection — producing an average of 22.5% body weight loss at 15mg over 72 weeks in the landmark SURMOUNT-1 trial. For patients in London and Greater London, access comes through two routes: NHS prescription via tier 3 specialist services (with significant waiting times), or private prescription through a GPhC-registered provider like Slinic with next-day delivery.

This guide covers everything a London patient needs to know: NHS eligibility and waiting times in 5 ICBs across London sub-regions, how to access private Mounjaro at fixed 2026 prices, eligibility criteria, dosing, and what to expect.

Obesity in London: The Local Picture

London has an adult obesity rate of approximately 26% — representing around 2.5 million people across the 32 boroughs. Rates vary significantly: Tower Hamlets, Newham, Barking and Dagenham, and Hackney have some of the highest rates in the country (above 30%), driven by socioeconomic deprivation, food environment, and lower physical activity rates. Affluent south-west London boroughs tend towards the lower end of the national range.

For South Asian Londoners — a major demographic across many east and north London boroughs — BMI thresholds for prescribing are adjusted downward: BMI 23+ with a qualifying condition, or 27.5+ without. Slinic applies these adjustments automatically at assessment.

How to Get Mounjaro in London: Two Routes

NHS Mounjaro in London: Current Status and Waiting Times

London is divided into five NHS Integrated Care Boards (ICBs), each implementing NHS Mounjaro and Wegovy at different speeds. Phase 2 (BMI 35+) is rolling out from June 2026.

Private Mounjaro in London: Slinic’s Fixed 2026 Prices

Slinic delivers MHRA-licensed Mounjaro from Eli Lilly’s authorised UK supply chain to Greater London next day. Fixed 2026 prices — no subscription, no minimum term, no hidden fees.

Each pen contains 4 weekly doses. Prices verified June 2026. No subscription — order when ready.

Am I Eligible for Mounjaro in London?

Eligibility for private Mounjaro at Slinic (the route available immediately, without NHS waiting lists) requires:

• BMI 30 or above — no qualifying condition needed
• BMI 27 or above with at least one qualifying condition: type 2 diabetes, hypertension, cardiovascular disease, high cholesterol, sleep apnoea, NAFLD, PCOS, or obesity-related osteoarthritis
• Age 18 or over
• No absolute contraindications — including no personal or family history of medullary thyroid carcinoma or MEN2; not pregnant or breastfeeding

What Slinic Includes for London Patients

The NHS Bridge Strategy for London Patients

For patients in London who are on the NHS waiting list (or want to get on it) while also wanting to start treatment now, the bridge strategy makes clinical sense:

1. Ask your GP today for a tier 3 weight management referral — this starts the NHS clock
2. Start Mounjaro privately at Slinic — your medication arrives in 24–48 hours, you begin losing weight while you wait
3. When your NHS tier 3 place comes through (typically 12–24 (varies by borough)+ months in London) — transition to NHS supply, typically at the same dose you’re already on

Starting private treatment does not affect your NHS eligibility or waiting list position. Your Slinic clinician can provide a treatment summary for your NHS tier 3 team when the time comes. See our full NHS Mounjaro guide for more detail →

Mounjaro vs Wegovy for London Patients

How to Get Started at Slinic — London Patients

1. Complete the free 2-minute eligibility assessment at slinic.co.uk/consultation
2. A registered Slinic prescriber reviews your assessment — typically within a few hours during working hours
3. If approved, your first Mounjaro or Wegovy pen is dispatched within 24 hours — cold-chain tracked delivery to your London address
4. Your free monthly check-in is scheduled — weight progress, dose management, side effect review, all included

Frequently Asked Questions — Mounjaro in London

Who Prescribes Mounjaro in London — And What to Look For

Searching “Mounjaro London” returns dozens of providers. Not all of them offer the same standard of clinical care. Here is exactly what to verify before choosing any London Mounjaro provider — NHS or private:

Mounjaro in London: The Complete Clinical Results

For London patients starting Mounjaro, here is the full picture of what the clinical evidence shows — matched to realistic timelines:

How Mounjaro Compares to Other Weight Loss Methods Available in London

London patients have access to the full range of weight loss interventions — from NHS lifestyle services through to private bariatric surgery. Here is how Mounjaro compares:

Mounjaro achieves weight loss results comparable to gastric sleeve surgery without the perioperative risk, hospital admission, or irreversibility. It is now positioned in clinical guidelines as a first-line intervention to consider before bariatric surgery for many patients — a fundamental shift in obesity treatment philosophy.

London-Specific Considerations: Who Qualifies and Ethnic Group Adjustments

London is one of the most ethnically diverse cities in the world. For weight loss injection prescribing, this has significant clinical implications:

Standard eligibility thresholds

• BMI 30 or above — no qualifying condition required
• BMI 27–29.9 with at least one qualifying condition

Adjusted thresholds for London’s diverse communities

The following groups qualify at lower BMI thresholds due to documented higher metabolic risk at lower body weight:

These adjustments are clinically supported by NHS guidance and Slinic applies them automatically at assessment. For London patients from these backgrounds, this significantly expands who qualifies — particularly in East and North London boroughs with large South Asian and East African communities.

Practical Guide: Starting Mounjaro Privately in London

Here is the complete practical picture for a London patient starting Mounjaro privately through Slinic:

The process

1. Assessment (online, ~2 minutes): Complete the eligibility assessment at slinic.co.uk/consultation. Your height, weight, BMI, medical history, current medications, and qualifying conditions are all reviewed.
2. Prescriber review (same day): A registered Slinic prescriber reviews your assessment, checks all contraindications and drug interactions, and approves or queries your prescription.
3. Dispatch (within 24 hours): Your Mounjaro KwikPen is dispatched in certified cold-chain packaging maintaining 2–8°C throughout transit. Tracked next-day delivery to your London address.
4. Injection day 1: The starter pack includes needles and a sharps bin. Full injection instructions are provided with every delivery. The auto-injector pen is simple to use — no clinical training required.
5. Monthly check-in (free): One month after starting, your Slinic prescriber reviews your weight, dose, side effects, and nutritional status. Dose escalation is managed at every monthly check-in.

Storage in London

Mounjaro pens must be stored at 2–8°C (in a refrigerator — not the freezer) before first use, and can be kept at room temperature below 30°C for up to 21 days after opening. In London’s warmer summer months (where temperatures occasionally exceed 30°C), plan storage carefully — keep the pen in the refrigerator and take it out only on injection day.

Injection days and commuting

Mounjaro is once-weekly — inject on the same day each week. Most London patients choose a fixed day (e.g. Sunday evening) when they are home and relaxed rather than on a work commute. The pen is compact enough to carry if needed, stored in a cool bag for journeys over 30 minutes in warm weather.

NHS Mounjaro in London: How to Get Referred

For London patients who want to pursue the NHS route — or who want to be on the NHS waiting list while accessing private treatment simultaneously — here is the referral process:

1. Book an appointment with your GP. Ask specifically for a “tier 3 weight management referral” or “NICE TA1026 Mounjaro referral.” Having a clear ask makes the conversation more efficient.
2. Confirm your eligibility criteria. From June 2026, tier 3 referral for Mounjaro requires BMI 35+ with at least 4 qualifying conditions. If you have a BMI below 35 or fewer than 4 conditions, discuss the Wegovy cardiovascular pathway if you have established CVD (BMI 27+, no T2D).
3. Your GP refers you to your ICB’s tier 3 service. In London, this depends on your borough. Ask your GP which specific service covers your postcode and what the current waiting time is.
4. Join the waiting list. Waiting times in London range from 12 to 24 months depending on borough. You are on the list — and can access private Mounjaro through Slinic in the meantime.

The Mounjaro Dosing Schedule for London Patients

Mounjaro follows a structured escalation protocol regardless of where you get it — NHS tier 3 or Slinic. Here is the complete schedule:

Some patients remain at 10mg or 12.5mg rather than escalating to 15mg — if the results are satisfactory and the dose is well tolerated, there is no clinical requirement to escalate further. Your Slinic monthly check-in determines the appropriate dose for your individual progress.

Mounjaro Side Effects: What London Patients Should Expect

The most common Mounjaro side effects are gastrointestinal — nausea, diarrhoea, constipation, and vomiting. These are most pronounced in the first 2–4 weeks at each new dose and typically improve as the body adapts. Here is the frequency data from SURMOUNT-1 at 15mg:

Mounjaro for London Patients with Type 2 Diabetes

Mounjaro (tirzepatide) is uniquely positioned among weight loss medications because it holds a dual licence — both for weight management and for type 2 diabetes. For London patients with T2D, this is clinically significant:

• Mounjaro produces significant HbA1c reduction alongside weight loss — typically 2–3 percentage points at maximum doses
• As blood sugar improves, existing diabetes medications (particularly insulin and sulphonylureas) may need dose reduction — coordinate with your GP or diabetes team throughout treatment
• The April 2026 QOF update means some London GP practices now include Mounjaro within their T2D prescribing pathway — ask your GP whether their practice participates
• NICE TA1026 (Mounjaro for obesity) has lower eligibility criteria than the T2D pathway — BMI 35+ with 4 conditions versus some T2D-specific criteria

Wegovy in London: The Cardiovascular Pathway (April 2026)

For London patients with established cardiovascular disease, the April 2026 NICE approval of Wegovy creates a new, potentially faster NHS route that bypasses the tier 3 obesity pathway:

London has a high prevalence of cardiovascular disease, particularly in areas with older populations (outer south London) and in communities with historically high rates of T2D and hypertension (much of East and North London). The SELECT trial showed that Wegovy reduces cardiovascular events by 20% in eligible patients — a profound public health impact for London.

References and Further Reading

1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
2. NICE TA1026 — Tirzepatide for managing overweight and obesity. 2025. nice.org.uk/guidance/ta1026
3. NICE TA875 — Semaglutide for managing overweight and obesity. 2023.
4. 5 ICBs across London sub-regions. NHS commissioning guidance for weight management medications. June 2026.
5. GPhC. Guidance for registered pharmacies providing services at a distance. February 2025. pharmacyregulation.org
6. Health Survey for England 2024 / Scottish Health Survey 2024. Adult obesity statistics.

Related Guides